Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population.

Scientific reports·2025

Same author

Association of chronic neutrophil activation with risk of mortality.

PloS one·2023

Same author

Reduced hypoglycaemia using liver-targeted insulin in individuals with type 1 diabetes.

Diabetes, obesity & metabolism·2022

Same author

Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.

Journal of Alzheimer's disease : JAD·2021

Same author

Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.

Journal of the American College of Cardiology·2019

Same author

Preliminary Investigation on the Association between Depressive Symptoms and Driving Performance in Heart Failure.

Geriatrics (Basel, Switzerland)·2019

Search research articles

Related Experiment Video

Updated: May 10, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Stem cell therapy for heart disease.

Shannon B Puliafico¹, Marc S Penn, Kevin H Silver

¹Northeast Ohio Cardiovascular Specialists (NEOCS), 95 Arch St. Suite 300, Akron, OH, 44304, USA.

Journal of General Internal Medicine

|June 18, 2013

Summary

This summary is machine-generated.

Stem cell therapy shows promise for treating heart damage after myocardial infarction, improving ventricular function and reducing infarct size. Further research into mechanisms like paracrine factors is ongoing.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: May 10, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

Cardiology
Regenerative Medicine
Biomedical Engineering

Background:

Coronary artery disease remains a leading cause of mortality.
Myocardial infarction often results in persistent ventricular damage despite current treatments.
Existing therapeutic options do not fully restore cardiac function post-infarction.

Purpose of the Study:

To provide a comprehensive overview of stem cell therapy for cardiac repair.
To discuss the potential of stem cells in restoring myocardial function.
To explore future directions in cardiac stem cell research and application.

Main Methods:

Review of clinical trial data on stem cell therapy for cardiovascular conditions.
Analysis of proposed mechanisms underlying stem cell efficacy.
Synthesis of current understanding of stem cell-mediated paracrine signaling.

Main Results:

Clinical trials indicate safety and efficacy of stem cell therapy in patients with acute myocardial infarction, heart failure, and dilated cardiomyopathy.
Observed benefits include enhanced ventricular function, increased ejection fraction, and reduced infarct size.
Paracrine factors, such as stromal cell-derived factor-1, are implicated in stem cell therapeutic effects.

Conclusions:

Stem cell therapy presents a promising approach to address myocardial damage and improve cardiac function.
Understanding the underlying mechanisms, particularly paracrine signaling, is crucial for optimizing therapeutic strategies.
Continued research and clinical investigation are essential to fully realize the potential of stem cell therapy in cardiology.